Health Research with Big Data: Time for Systemic Oversight
暂无分享,去创建一个
[1] Kerina H. Jones,et al. The other side of the coin: harm due to the non-use of health-related data , 2016, Int. J. Medical Informatics.
[2] Alessandro Blasimme,et al. Biomedical Big Data: New Models of Control Over Access, Use and Governance , 2017, Journal of Bioethical Inquiry.
[3] Marcel Salathé,et al. Precision global health in the digital age. , 2017, Swiss medical weekly.
[4] J. Stilgoe,et al. Developing a framework for responsible innovation* , 2013, The Ethics of Nanotechnology, Geoengineering and Clean Energy.
[5] A. Cambon-Thomsen,et al. Genomic Incidental Findings: Reducing the Burden to Be Fair , 2013, The American journal of bioethics : AJOB.
[6] I. Kohane,et al. Finding the missing link for big biomedical data. , 2014, JAMA.
[7] Helge Toutenburg,et al. The Social Control of Technology , 1982 .
[8] Audley Genus. Rethinking constructive technology assessment as democratic, reflective, discourse , 2006 .
[9] Robert Cook-Deegan,et al. Broad Consent for Research With Biological Samples: Workshop Conclusions , 2015, The American journal of bioethics : AJOB.
[10] J. Voss,et al. The Politics of Reflexive Governance: Challenges for Designing Adaptive Management and Transition Management , 2011 .
[11] E. Vayena,et al. Digital health: meeting the ethical and policy challenges. , 2018, Swiss medical weekly.
[12] Marcel Salathé,et al. Ethical Challenges of Big Data in Public Health , 2015, PLoS Comput. Biol..
[13] Vilhjalmur Arnason,et al. Coding and Consent: Moral Challenges of the Database Project in Iceland , 2004, Bioethics.
[14] Eric Elenko,et al. Defining digital medicine , 2015, Nature Biotechnology.
[15] R. Rhodes,et al. The New Governance: Governing without Government , 1996 .
[16] Stacey Pereira,et al. Should you profit from your genome? , 2017, Nature Biotechnology.
[17] A Cecile J W Janssens,et al. A tiered-layered-staged model for informed consent in personal genome testing , 2012, European Journal of Human Genetics.
[18] G. Laurie. Reflexive governance in biobanking: on the value of policy led approaches and the need to recognise the limits of law , 2011, Human Genetics.
[19] G. Henderson. Is Informed Consent Broken? , 2011, The American journal of the medical sciences.
[20] David H. Guston,et al. Real-time technology assessment , 2020, Emerging Technologies: Ethics, Law and Governance.
[21] Urs Gasser,et al. Elements of a new ethical framework for big data research , 2016 .
[22] Brian W. Powers,et al. The digital phenotype , 2015, Nature Biotechnology.
[23] Barbara J. Evans,et al. Barbarians at the Gate , 2016, American Journal of Law & Medicine.
[24] George Packer. The Broken Contract , 2011 .
[25] Pascal Borry,et al. From the principles of genomic data sharing to the practices of data access committees , 2015, EMBO molecular medicine.
[26] W. Nicholson Price,et al. Black-Box Medicine , 2014 .
[27] Ruben Amarasingham,et al. The legal and ethical concerns that arise from using complex predictive analytics in health care. , 2014, Health affairs.
[28] B. Elger,et al. Consent and anonymization in research involving biobanks , 2006, EMBO reports.
[29] L. Rich. Prestidigitation vs. Public Trust: Or How We Can Learn to Change the Conversation and Prevent Powers From “Organizing the Discontent” , 2017, Journal of Bioethical Inquiry.
[30] Barbara J Evans,et al. Power to the People: Data Citizens in the Age of Precision Medicine. , 2017, Vanderbilt journal of entertainment and technology law.
[31] G. Church,et al. From genetic privacy to open consent , 2008, Nature Reviews Genetics.
[32] E. Emanuel,et al. The debate over research on stored biological samples: what do sources think? , 2002, Archives of internal medicine.
[33] E. Vayena,et al. Becoming partners, retaining autonomy: ethical considerations on the development of precision medicine , 2016, BMC medical ethics.
[34] B. Koenig,et al. Linking Broad Consent to Biobank Governance: Support From a Deliberative Public Engagement in California , 2015, The American journal of bioethics : AJOB.
[35] E. Vayena,et al. Opinion: Learning as we go: Lessons from the publication of Facebook’s social-computing research , 2014, Proceedings of the National Academy of Sciences.
[36] A. McGuire,et al. Informed consent in genomics and genetic research. , 2010, Annual review of genomics and human genetics.
[37] S. Beck,et al. Dynamic Consent: a potential solution to some of the challenges of modern biomedical research , 2017, BMC Medical Ethics.
[38] R. Gallagher,et al. From consent to institutions: designing adaptive governance for genomic biobanks. , 2011, Social science & medicine.
[39] E. Vayena,et al. Informed Consent and the Disclosure of Clinical Results to Research Participants , 2017, The American journal of bioethics : AJOB.
[40] Frank A. Pasquale. The Black Box Society: The Secret Algorithms That Control Money and Information , 2015 .
[41] Kyle Kubler. The Black Box Society: the secret algorithms that control money and information , 2016 .
[42] Matthew Kearnes,et al. Nanotechnology, Governance, and Public Deliberation: What Role for the Social Sciences? , 2005 .
[43] Taha A. Kass-Hout,et al. Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in Twitter , 2014, Drug Safety.
[44] D. Collingridge. The social control of technology , 1980 .
[45] E. Vayena,et al. Caught in the Web: Informed Consent for Online Health Research , 2013, Science Translational Medicine.
[46] E. Vayena,et al. “Tailored-to-You”: Public Engagement and the Political Legitimation of Precision Medicine , 2017, Perspectives in biology and medicine.
[47] L. Floridi. The Onlife Manifesto: Being Human in a Hyperconnected Era , 2014 .
[48] A. Cambon-Thomsen,et al. Disclosing Results to Genomic Research Participants: Differences That Matter , 2012, The American journal of bioethics : AJOB.
[49] Joakim Dillner,et al. Should donors be allowed to give broad consent to future biobank research? , 2006, The Lancet. Oncology.
[50] Gurumurthy Ramachandran,et al. Recommendations for oversight of nanobiotechnology: dynamic oversight for complex and convergent technology , 2011, Emerging Technologies: Ethics, Law and Governance.
[51] S. Vadhan,et al. Integrating Approaches to Privacy Across the Research Lifecycle: When Is Information Purely Public? , 2015 .
[52] Jeremy Sugarman,et al. Examining Provisions Related to Consent in the Revised Common Rule , 2017, The American journal of bioethics : AJOB.
[53] B. Koenig. Have we asked too much of consent? , 2014, The Hastings Center report.
[54] B Hofmann,et al. Broadening consent—and diluting ethics? , 2009, Journal of Medical Ethics.
[55] D. Wendler. Broad versus blanket consent for research with human biological samples. , 2013, The Hastings Center report.
[56] G. Helgesson. In Defense of Broad Consent , 2011, Cambridge Quarterly of Healthcare Ethics.
[57] Timothy Caulfield,et al. DNA databanks and consent: A suggested policy option involving an authorization model , 2003, BMC medical ethics.
[58] T. Tomlinson. Respecting donors to biobank research. , 2013, The Hastings Center report.
[59] Urs Gasser,et al. “Strictly Biomedical? Sketching the Ethics of the Big Data Ecosystem in Biomedicine” , 2016 .
[60] F. Collins,et al. A new initiative on precision medicine. , 2015, The New England journal of medicine.
[61] John Grin,et al. Contextualizing Reflexive Governance: the Politics of Dutch Transitions to Sustainability , 2007 .
[62] Michael Morrison,et al. Dynamic consent: a patient interface for twenty-first century research networks , 2014, European Journal of Human Genetics.
[63] J. Brownstein,et al. Digital disease detection--harnessing the Web for public health surveillance. , 2009, The New England journal of medicine.
[64] Fred H. Cate,et al. Notice and consent in a world of Big Data , 2013 .
[65] E. Vayena,et al. Genetic incidental findings: autonomy regained? , 2013, Genetics in Medicine.
[66] W. Riley,et al. Precision Public Health for the Era of Precision Medicine. , 2016, American journal of preventive medicine.
[67] Joanne Scott,et al. Mind the Gap: Law and New Approaches to Governance in the European Union , 2002 .
[68] A. Sheikh,et al. Policy implications of big data in the health sector , 2017, Bulletin of the World Health Organization.
[69] Thomas J. Misa,et al. Constructive Technology Assessment: A New Paradigm for Managing Technology in Society , 1995 .
[70] D. Nafus. Quantified: Biosensing Technologies in Everyday Life , 2016 .
[71] Erika Check Hayden,et al. Informed consent: A broken contract , 2012, Nature.
[72] S. Holm,et al. Ethical Endgames: Broad Consent for Narrow Interests; Open Consent for Closed Minds , 2011, Cambridge Quarterly of Healthcare Ethics.